EDP Sciences logo
Subscriber Authentication Point
Search
Menu
Home All issues Volume 27 / No 10 (Octobre 2011) Med Sci (Paris), 27 10 (2011) 805-807 References
Free Access
Issue
Med Sci (Paris)
Volume 27, Number 10, Octobre 2011
Page(s) 805 - 807
Section Nouvelles
DOI https://doi.org/10.1051/medsci/20112710004
Published online 21 October 2011
  1. Coulombel L. Reprogrammation nucléaire d’une cellule différenciée : on efface tout et on recommence. Med Sci (Paris) 2007 ; 23 : 667–670. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  2. Stadtfeld M, Hochedlinger K. Induced pluripotency: history, mechanisms, and applications. Genes Dev 2010 ; 24 : 2239–2263. [Google Scholar]
  3. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006 ; 126 : 663–676. [CrossRef] [PubMed] [Google Scholar]
  4. Zhao X, Li W, Lv Z, et al. iPS cells produce viable mice through tetraploid complementation. Nature 2009 ; 461 : 86–90. [CrossRef] [PubMed] [Google Scholar]
  5. Lapasset L, Milhavet O, Lemaitre JM. La reprogrammation vers la pluripotence peut-elle effacer la mémoire d’une vie antérieure ? Med Sci (Paris) 2010 ; 26 : 902–903. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  6. Lister R, Pelizzola M, Kida YS, et al. Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells. Nature 2011 ; 471 : 68–73. [CrossRef] [PubMed] [Google Scholar]
  7. Zhao T, Zhang ZN, Rong Z, Xu Y. Immunogenicity of induced pluripotent stem cells. Nature 2011 ; 474 : 212–215. [PubMed] [Google Scholar]
  8. Gore A, Li Z, Fung HL, et al. Somatic coding mutations in human induced pluripotent stem cells. Nature 2011 ; 471 : 63–67. [CrossRef] [PubMed] [Google Scholar]
  9. Hussein SM, Batada NN, Vuoristo S, et al. Copy number variation and selection during reprogramming to pluripotency. Nature 2011 ; 471 : 58–62. [CrossRef] [PubMed] [Google Scholar]
  10. Pasi CE, Dereli-Öz A, Negrini S, et al. Genomic instability in induced stem cells. Cell Death Diff 2011 ; 18 : 745–753. [CrossRef] [Google Scholar]
  11. Dijon-Grinand M, De Vos J. P53, ARF et P16 : la ligne Maginot de la reprogrammation cellulaire. Med Sci (Paris) 2009 ; 25 : 793–794. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  12. Guenther MG, Frampton GM, Soldner F, et al. Chromatin structure and gene expression programs of human embryonic and induced pluripotent stem cells. Cell Stem Cell 2010 ; 7 : 249–257. [CrossRef] [PubMed] [Google Scholar]
  13. Stadtfeld M, Apostolou E, Akutsu H, et al. Aberrant silencing of imprinted genes on chromosome 12qF1 in mouse induced pluripotent stem cells. Nature 2010 ; 465 : 175–181. [CrossRef] [PubMed] [Google Scholar]
  14. Taapken SM, Nisler BS, Newton MA, et al. Kariotypic abnormalities in human induced pluripotent stem cells and embryonic stem cells. Nat Biotech 2011 ; 29 : 313–314. [CrossRef] [Google Scholar]
  15. Nicaise C, Bohl D, Pochet P. La transdifferenciation cellulaire au service de la sclérose latérale amyotrophique ?. Med Sci (Paris) 2011 ; 27 : 799–801. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  16. Coulombel L. Pluripotence : une définition à géométrie variable. Med Sci (Paris) 2009 ; 25 : 798–801. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  17. Coulombel L. Les iPS : soi ou non-soi ? Med Sci (Paris) 2011 ; 27 : 715–716. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.